MedPath

A Study on Pazhathennai in the mangement of Aseerana pitham (GERD)

Phase 2
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Registration Number
CTRI/2023/08/056729
Lead Sponsor
ational institute of siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient who are having symptoms of Aseerana pitham-GERD

Regurgitation

Heartburn

Increased salivation

Patient must have atleast any 2 of the following symptoms

Bloating

Pain in epigastric pain

Early satiety

Flatulance

Discomfort in the chest

Patient with endoscopic evidence suggestive of GERD

Patient who are willing to sign informed consent form

Exclusion Criteria

Peptic ulcer

Pancreatitis

Appendicitis

Pregnancy and lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Gastroesophageal reflux disease symptom assessment scale GSAS Scale will be assed before & after treatmentTimepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath